November 16, 2014
Weighing the Week Ahead: Time to Buy Commodities?
…..Other Advice
Here is our collection of great investor advice for this week:
Stock ideas! The very hot biotech sector has pulled back a bit. (For traders, Felix actually has it as one of the few sectors that is not worth a “fresh money†buy on the three-week time horizon). Fair enough. Investors should look for great entry points, but the issues are a bit different because of the potential gain. Investors do not want to miss out on a big move.
In our relatively new (one year) High Octane program we seek out stocks with exceptional potential and accept a higher level of volatility. Biotech is one of the various themes, and the Medical Technology Stock Letter is a source we follow closely. It has helped us into two big biotech winners this year ( and ISIS) and there is a new recommendation related to Ebola.
I have written about this threat for many months and the fluctuations in the “Ebola stocks†have been dramatic. Does anyone think we have reached the end of this story? I like the idea of a vaccine, and Novavax (NVAX) is the leader.
Thanks to John McCamant for sharing a free report with our readers, including this: